Market Overview

UPDATE: Sterne Agee Upgrades athenahealth to Neutral; Overhang Removed

Share:
Related ATHN
5 Biggest Price Target Changes For Tuesday
Benzinga's Top Upgrades, Downgrades For February 7, 2017

Sterne Agee raised its rating on athenahealth (NASDAQ: ATHN) from Underperform to Neutral and increased its price target from $48.50 to $72.

Sterne Agee noted, "Contrary to our fears toward a significant air pocket in revenues created by the loss of a material channel partnership with PSS World Medical (PSSI, $28.48, NR), we now believe this relationship will continue. In hindsight, our industry checks had caused our view towards the ATHNPSSI partnership to become black and white, whereby we thought the partnership would end upon the consummation of PSSI's marriage with McKesson (MCK, $95.30, NR). We now believe McKesson will allow the PSS sales force the option to sell athena's solutions or MCK's solutions"

athenahealth closed at $73.89 on Friday.

Latest Ratings for ATHN

DateFirmActionFromTo
Feb 2017BerenbergInitiates Coverage OnBuy
Jan 2017Cantor FitzgeraldInitiates Coverage OnOverweight
Jan 2017KeyBancUpgradesSector WeightOverweight

View More Analyst Ratings for ATHN
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (ATHN)

View Comments and Join the Discussion!